817-824
Original Article
Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates
Shana Jacobs, Cynthia L. McCully, Robert F. Murphy, John Bacher and Frank M. Balis, et al.
825-831
Original Article
Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases
Hidekazu Kuramochi, Kazuhiko Hayashi, Go Nakajima, Hirotaka Kamikozuru and Masakazu Yamamoto, et al.
833-838
Original Article
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors
Yelena Y. Janjigian, Wooin Lee, Mark G. Kris, Vincent A. Miller and Lee M. Krug, et al.
839-848
Original Article
Limited inter-occasion variability in relation to inter-individual variability in chemotherapy-induced myelosuppression
Emma K. Hansson, Johan E. Wallin, Henrik Lindman, Marie Sandström and Mats O. Karlsson, et al.
849-861
Original Article
Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials
Lidan Liu, Yunfei Cao, Aihua Tan, Cun Liao and Feng Gao
863-869
Original Article
A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies
Tanios Bekaii-Saab, Marisa Hill, Angela Campbell, Kavitha Kosuri and James Thomas, et al.
871-876
Original Article
A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer
Andrea Rocca, Roberta Maltoni, Alessandro Passardi, Ilaria Massa and Michele Aquilina, et al.
877-888
Original Article
Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol
S. J. Greay, D. J. Ireland, H. T. Kissick, A. Levy and M. W. Beilharz, et al.
889-893
Original Article
Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors
Takashi Shida, Takashi Kishimoto, Mitsuko Furuya, Takashi Nikaido and Keiji Koda, et al.
895-902
Original Article
Open AccessArtesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo
Ji-Hui Du, Hou-De Zhang, Zhen-Jian Ma and Kun-Mei Ji
903-911
Original Article
Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line
Karnati R. Roy, Gorla V. Reddy, Leela Maitreyi, Smita Agarwal and Chandrani Achari, et al.
913-921
Original Article
Optimization of the non-invasive 13C-sucrose breath test in a rat model of methotrexate-induced mucositis
K. L. Tooley, G. S. Howarth, K. A. Lymn and R. N. Butler
923-930
Original Article
Open AccessPreclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane
Zhongling Feng, Gang Zhao, Lei Yu, David Gough and Stephen B. Howell
931-940
Original Article
Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model
Nohemí Salinas-Jazmín, Marisol de la Fuente, Ruth Jaimez, Mayra Pérez-Tapia and Armando Pérez-Torres, et al.
941-951
Original Article
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase
Frederick H. Hausheer, Dakshine Shanmugarajah, Betsy D. Leverett, Xinghai Chen and Quili Huang, et al.
953-959
Original Article
Co-administration of irinotecan decreases the plasma concentration of an active metabolite of amrubicin, amrubicinol in rats
Yukiko Maeda, Akinobu Hamada, Emiko Sanematsu, Ji-ichro Sasaki and Koji Yokoo, et al.
961-967
Original Article
Open AccessPhase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
Akira Sawaki, Yasuhide Yamada, Yoshito Komatsu, Tatsuo Kanda and Toshihiko Doi, et al.
969-978
Original Article
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy
Rhys D. Clyburn, Penny Reid, Catherine A. Evans, Diane V. Lefley and Ingunn Holen
979-988
Clinical Trial Report
A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy
Peter M. Wilson, Anthony El-Khoueiry, Syma Iqbal, William Fazzone and Melissa J. LaBonte, et al.
989-994
Short Communication
DNA damage induced by the anthracycline cosmomycin D in DNA repair-deficient cells
Helotonio Carvalho, Leandro M. Garrido, Renata L. A. Furlan, Gabriel Padilla and Mateus Agnoletto, et al.
995-1000
Short Communication
Open AccessIn vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine
Yong Chen, Lisa Liu, Eric Laille, Gondi Kumar and Sekhar Surapaneni
1001-1004
Short Communication
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab
Brett L. Gourley, Hector Mesa and Pankaj Gupta